Vanderbilt Joins National Trial of Tirzepatide in Opioid Use Disorder Research

Vanderbilt Health is enrolling participants for a national study examining tirzepatide alongside buprenorphine treatment for opioid use disorder. The randomized trial is investigating a new research question; it has not reported outcomes or established a new use for the medicine.

For research use only. Not for human consumption.